EnlitenAI provides a device-agnostic, context-aware AI platform for neurological and neurobehavioral disorder treatment decisions. This platform transforms passive monitoring data into actionable insights for proactive, personalized interventions. It enables precision drug and device titration by integrating multimodal data streams from wearables and implantables.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Managing epilepsy effectively is challenging due to the difficulty in accurately quantifying seizure burden and the delays in adjusting treatment plans. Traditional methods often rely on patient self-reporting or infrequent clinical visits, leading to imprecise data and prolonged titration cycles. This can result in suboptimal seizure control and increased risk for patients.
Solution
EnlitenAI offers Neuroliten, a device-agnostic platform that leverages wearable technology and AI to provide remote monitoring and personalized management of epilepsy. The platform gathers real-world evidence to generate individualized insights, enabling more precise seizure burden calculations and informed treatment decisions. By continuously collecting and analyzing data, Neuroliten aims to optimize antiepileptic medication titrations, improve seizure control, and enhance overall patient outcomes. The AI engine facilitates data monetization through the creation of personalized insights derived from real-world evidence.
Target Audience
The primary target audience includes neurologists, epileptologists, and other healthcare providers involved in the management of epilepsy, as well as patients with epilepsy and their caregivers.
Features
- Device-agnostic platform compatible with various wearable sensors for continuous data collection
- AI-powered engine for analyzing real-world evidence and generating personalized insights
- Remote monitoring capabilities for tracking seizure activity and related physiological parameters
- Precise seizure burden calculations to inform treatment adjustments
- Data-driven insights to optimize antiepileptic medication titrations
- Secure data storage and HIPAA compliance